CCL2 and COVID-19: Amongst the COVID-19 patients, greatly elevated levels of inflammatory cytokines/chemokines were detected in respiratory samples across ETA, sputum and BAL specimens, with concentrations being 160× (MCP-1), 90× (IL-6) and 110× (IL-8) higher than in plasma (Fig. 2a).